Mandate

Vinge advises Industrifonden and SEB in connection with Clavister investment

April 16, 2012

Vinge has advised Industrifonden and SEB Venture Capital in connection with their approximately SEK 40 million investment in the security company Clavister AB. The company, which has its registered office in Örnsköldsvik, offers advanced security products focusing on the telecoms industry, cloud computing environments and large corporate customers. The capital will be used for the company’s future international expansion.

SEB Venture Capital was founded in 1995 and is part of the SEB group. With a capital base of SEK 2 500 million, the company has thus far made 36 investments in technology and healthcare enterprises and performed 36 exits. Read more about SEB Venture Capital by visiting www.seb.se/venturecapital

Industrifonden has assets worth SEK 3.8 billion and investments in 89 companies within the technology, cleantech, life science and industrial sectors. This is Industrfonden’s seventh new investment for the financial year comprising 1 July 2011 to 30 June 2012. Read more about Industrifonden by visiting www.industrifonden.se

Vinge’e team consisted of partner Johan Larsson together with associates Philip Watson and Martin Hall.     

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025